SCHEMBL901587

SCHEMBL901587

CCCCCCCCc1ccc(C(C(C)=O)[N+](=O)[O-])cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 1/20 0.48
CYSLTR1 Q9Y271 1/20 0.48
THRA P10827 5/20 0.48
THRB P10828 5/20 0.48
ALDH1A1 P00352 3/20 0.46
ESR1 P03372 2/20 0.46
ADRA2A P08913 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
TACR2 P21452 2/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A3 Q01959 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
SHBG P04278 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
HSPD1 P10809 1/20 0.46
ADRB3 P13945 1/20 0.46
HTR2C P28335 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16915553 0.78 KCNH2 (0.49) CYSLTR2CYSLTR1ALDH1A1ESR1ADRA2A
SCHEMBL10477134 0.77 RARB (0.56) THRATHRBALDH1A1HAO1RARB
SCHEMBL902106 0.76 SPHK1 (0.48) CYSLTR2CYSLTR1ALDH1A1ESR1ADRA2A
SCHEMBL15880521 0.75 KCNH2 (0.44) CYSLTR2CYSLTR1ALDH1A1ESR1ADRA2A
SCHEMBL13733545 0.74 THRA (0.52) THRATHRBALDH1A1HAO1RARB
SCHEMBL16915555 0.74 THRB (0.48) CYSLTR2CYSLTR1THRATHRBALDH1A1
SCHEMBL2732070 0.73 KCNH2 (0.45) CYSLTR2CYSLTR1THRATHRBALDH1A1
SCHEMBL903502 0.73 ESR1 (0.45) CYSLTR2CYSLTR1ALDH1A1ESR1ADRA2A
SCHEMBL15960543 0.73 ALDH1A1 (0.45) CYSLTR2CYSLTR1THRATHRBALDH1A1
Acetic Acid SCHEMBL28904115 0.73 CYSLTR2 (0.56) CYSLTR2CYSLTR1THRATHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632889-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD Mapi Pharma Limited (IL) 2013-09-04 EP claimed
WO-2012056458-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD MAPI PHARMA LTD. (IL) 2012-05-03 WO claimed
EP-2632889-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD Mapi Pharma Limited (IL) 2013-09-04 EP disclosed
EP-2621886-A1 PROCESS FOR MAKING FINGOLIMOD Synthon BV (NL) 2013-08-07 EP disclosed
WO-2012056458-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD MAPI PHARMA LTD. (IL) 2012-05-03 WO disclosed
WO-2012041359-A1 PROCESS FOR MAKING FINGOLIMOD SYNTHON B.V. (NL) 2012-04-05 WO disclosed
WO-2012041405-A1 PROCESS FOR MAKING FINGOLIMOD SYNTHON B.V. (NL) 2012-04-05 WO disclosed
WO-2012041707-A1 PROCESS FOR MAKING FINGOLIMOD SYNTHON BV (NL) 2012-04-05 WO disclosed